CMMB — Chemomab Therapeutics Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1534248 · Israel
Last close
$1.64
Market Cap
$12.02M
52W High
$2.99
52W Low
$0.92
ADV30
54,617
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -2,241,000 -2,165,000 10,238,000 5,999,000 1,553,000
Mar 2026 0 — -1,850,000 -1,773,000 11,808,000 5,906,000 1,113,000
Dec 2025 0 — -1,974,000 -1,873,000 13,812,000 7,564,000 1,478,000
Sep 2025 0 — -1,844,000 -1,742,000 12,368,000 6,974,000 1,137,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-115,556,000
Inventory
—
Receivables
$3,270,000
ST Investments
$688,000
EBIT TTM
$-7,909,000
Pretax Income TTM
$-7,553,000
Interest Exp TTM
—
Analysts
1

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -9,567,000 -8,995,000 13,812,000 1,478,000 12,334,000 -11,130,000
Dec 2024 0 -14,739,000 -13,945,000 16,964,000 3,427,000 13,537,000 -15,386,000
Dec 2023 0 -25,459,000 -24,221,000 22,151,000 5,154,000 16,997,000 -23,611,000
Dec 2022 0 -28,533,000 -27,646,000 43,063,000 6,840,000 36,223,000 -20,370,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
$31,295,000
OpCashFlow TTM
—
Assets (Latest)
$35,013,000
Forward EPS
$-0.03

Peers — same industry

TickerNameMarket CapLastDaily %
OPTH Optimi Health Corp. $12.02M $2.10 —
NEUP Neuphoria Therapeutics Inc. $12.27M $2.27 —
ASBP Aspire-Lakewood Holdings, Inc. $11.64M $8.30 —
MTNB Matinas BioPharma Holdings, Inc. $12.57M $0.86 —
LSTA LISATA THERAPEUTICS, INC. $11.24M $1.04 —

News headlines (Yahoo Finance, 1h cache)

Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective
2026-11-02 13:00 · Yahoo
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
2026-08-19 12:26 · Yahoo
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
2026-07-08 11:35 · Yahoo
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-14 12:00 · Yahoo
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
2026-08-31 12:00 · Yahoo
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
2026-03-19 12:00 · Yahoo
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
2026-02-17 13:00 · Yahoo
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
2025-12-02 13:00 · Yahoo
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
2025-11-24 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.